People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Blue Current, Inc. | — | Other Technology | Series C | $127.2M | $522.1M | 2022 |
| Liquidia Technologies Inc | — | Biotechnology | Series B | $86.7M | $890.0M | 2009 |
| Teal Health, Inc. | — | Healthtech | Series B | $23.5M | $140.1M | 2024 |
| Omnipulse Biosciences, Inc. | — | Biotechnology | Series A | $7.0M | $47.8M | 2023 |
| Focal Medical, Inc. | — | Biotechnology | Series A | $6.4M | $5.9M | 2024 |
Joseph DeSimone at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph DeSimone on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Stephen Bloch | 1 | 15 |
| Ed Mathers | 1 | 11 |
| Isaac Cheng | 1 | 9 |
| Seth Rudnick | 1 | 5 |
| Nicole Johnson | 1 | 4 |
| Neal Fowler | 1 | 4 |
| Ralph Snyderman | 1 | 4 |
| Steve Nelson | 1 | 4 |
| Nessan Bermingham | 1 | 3 |
| Seth A. Rudnick | 1 | 3 |
| Louise Brady | 1 | 3 |
| Matthew Bettonville | 1 | 2 |
| Arthur S. Kirsch | 1 | 2 |
| Jon Chisolm | 1 | 2 |
| Ralph S. Snyderman | 1 | 2 |
| Neal F Fowler | 1 | 2 |
| David Zhu | 1 | 2 |
| Nitash Balsara | 1 | 2 |
| Arthur A. Kirsch | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.